Egrifta
Also known as Egrifta — this name points to Tesamorelin in our directory.
About Tesamorelin
An FDA-approved GHRH analog for HIV-associated visceral fat—one of the few legitimate prescription GH-axis peptides in the U.S.
Tesamorelin is a stabilized GHRH analog that increases GH and IGF-1. It is approved (as Egrifta) to reduce excess abdominal fat in HIV lipodystrophy. Bodybuilders sometimes discuss it for fat redistribution, but that is off-label. Requires medical supervision and carries GH-related side-effect risks.
Where you will see Egrifta
Egrifta is a marketing or trade name people search when they mean Tesamorelin. On retail shelves the INCI list on the back of the package may use a longer systematic name even when the front label shows a nickname.
Compare Tesamorelin
Other names
Egrifta
TH9507
Common questions
Is Egrifta the same as Tesamorelin?
Yes. Egrifta is a brand or nickname that refers to Tesamorelin in our directory—the same active molecule, different packaging or marketing name.
What is Tesamorelin?
An FDA-approved GHRH analog for HIV-associated visceral fat—one of the few legitimate prescription GH-axis peptides in the U.S. Tesamorelin is a stabilized GHRH analog that increases GH and IGF-1. It is approved (as Egrifta) to reduce excess abdominal fat in HIV lipodystrophy. Bodybuilders sometimes discuss it for fat redistribution, but that is off-label. Requires medical supervision and carries GH-related side-effect risks.
How do I find Egrifta on a label?
Egrifta may appear on retail product fronts, but confirm the INCI list matches Tesamorelin before assuming the formula is identical across brands.